Bimal R. Shah - 13 Jun 2024 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANEB	Stock Option (right to buy)	Award	$0	+41,667		$0.000000	41,667	13 Jun 2024	Common Stock	41,667	$2.10	Direct	F1
transaction	ANEB	Stock Option (right to buy)	Award	$0	+3,309		$0.000000	3,309	13 Jun 2024	Common Stock	3,309	$2.10	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant
F2	These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders